Samantha Semmeling

Jun 21, 2024 | publicpolicyprojects.com | Samantha Semmeling

Medicines are the second highest cost to the NHS after staffing and present an untapped opportunity to meet ICS strategic priorities and deliver better value for money. Outcomes-centred contractual frameworks and greater stakeholder collaboration between the NHS and industry is required to unlock value-based medicines optimisation.

May 28, 2024 | integratedcarejournal.com | Samantha Semmeling

By Public Policy Projects (PPP) recently spoke to Professor Mahendra Patel OBE, leading pharmacy expert and Director for the Centre for Research Equity at the University of Oxford, about his vision for community pharmacy, and how multi-professional collaboration can help the underutilised sector play a key role in the fight against health inequalities.

Apr 24, 2024 | integratedcarejournal.com | Samantha Semmeling

By Nuffield Trust report finds that while medicines shortages are now commonplace globally, they have become the ‘new normal’ in the UK, as organisations call on the government to conduct an urgent review into medicines supply chains.

Mar 28, 2024 | publicpolicyprojects.com | Dean Thompson |Samantha Semmeling |Gabriel Blaazer

By Professor James Kingsland OBE, Dean Thompson PhD and Samantha SemmelingKey insightsGP-provided primary healthcare services are under increasing pressure, with rising service demand, greater case complexities, and a proportionally smaller GP workforce. As the provision of integrated care services is extended into community settings through multidisciplinary team-based care, there needs to be a cultural shift among both clinicians and patients to changing dependency on a GP as first contact.

Jan 29, 2024 | integratedcarejournal.com | Samantha Semmeling

By Study proves efficacy of HPV vaccination at preventing cervical cancer, as UK Health Security Agency statistics show that uptake has still not returned to pre-pandemic levels. Public Health Scotland announced this week that a new study has found no cases of cervical cancer in young women vaccinated as part of the HPV vaccination programme.